Boothbay Fund Management’s Qiagen QGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$978K Buy
+25,000
New +$928K 0.01% 1108
2026
Q1
– Sell
-40,300
Closed -$1.81M – 2400
2025
Q4
$1.81M Buy
+40,300
New +$1.86M 0.03% 593
2024
Q4
– Sell
-25,278
Closed -$1.18M – 1840
2024
Q3
$1.18M Buy
+25,278
New +$1.15M 0.03% 703
2024
Q2
– Sell
-93,333
Closed -$4.13M – 1801
2024
Q1
$4.13M Buy
+93,333
New +$4.25M 0.08% 285

Other funds holding QGEN

Boothbay Fund Management's QGEN Position: Q2 2026 in Review

Boothbay Fund Management reduced its Qiagen (QGEN) stake by 57% in Q2 2026, selling an estimated $821K and leaving 16,828 shares worth $658K. The position accounts for 0.01% of the portfolio, ranked #1338.

Boothbay Fund Management first reported a position in QGEN in Q2 2017 and has held it in 16 quarters since. The position peaked at $1.56M in Q1 2026. 337 funds tracked by Wall St. Rank hold QGEN as of Q2 2026.

  • Boothbay Fund Management held 16,828 shares of Qiagen worth $658K as of Q2 2026.
  • Boothbay Fund Management sold 22,097 Qiagen shares in Q2 2026, an estimated $821K.
  • Qiagen made up 0.01% of Boothbay Fund Management's portfolio in Q2 2026, its #1338 holding.
  • Boothbay Fund Management first reported a position in Qiagen in Q2 2017 and has held it in 16 quarters since.
  • Boothbay Fund Management's Qiagen position peaked at $1.56M in Q1 2026.
  • 337 funds tracked by Wall St. Rank held Qiagen as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.